Inevitably, even minor alterations in FcRn binding properties of a protein fusion can therefore affect the ability of the receptor to rescue it from intracellular lysosomal degradation
The compounding pharmacy we partner with is fully accredited and adheres to all national standards for sterile compounding
Moreover, while the OUG defines an off-treatment period as at least 6 months, we defined it as 1 year, taking into account the rate of increase in BMI and other laboratory values after treatment discontinuation, as well as clinical expert opinion
GSH appears to be metabolically important in a wide variety of disease states, only a few of which have been discussed
Diabetes Technology & Therapeutics , 13(7), 735-742.
Food & Drug Administration, FDA approves first oral GLP-1 treatment for type 2 diabetes (2019)